In vitro anti-inflammatory activities of new steroidal antedrugs: [16α,17α-d] Isoxazoline and [16α,17α-d]-3′-hydroxy-iminoformyl isoxazoline derivatives of prednisolone and 9α-fluoroprednisolone
Keywords: ایسوکازولین; Anti-inflammatory steroidal antedrug; Drug design; Isoxazoline; Receptor-binding; NO production; Metabolism